Pliant therapeutics announces inducement grant under nasdaq listing rule 5635(c)(4)

South san francisco, calif., sept. 30, 2024 (globe newswire) -- pliant therapeutics, inc. (nasdaq: plrx), today announced that on september 30, 2024 it granted stock options to purchase an aggregate of 120,000 shares of common stock upon vesting to gary palmer, m.d., the company's newly appointed senior vice president of medical affairs as a material inducement to his employment.
NDAQ Ratings Summary
NDAQ Quant Ranking